Abstract
Genomic and full-length cDNA sequences provide opportunities for understanding human gene structure and transcriptional regulatory elements. The simplest regulatory elements to identify are promoters, as their positions are dictated by the location of transcription start sites. We aligned full-length cDNA clones from the Mammalian Gene Collection to the human genome rough draft sequence to estimate the start sites of more than 10,000 human transcripts. We selected genomic sequence just upstream from the 5' end of these cDNA sequences and designated these as putative promoters. We assayed the functions of 152 of these DNA fragments, chosen at random from the entire set, in a luciferase-based transfection assay in four human cultured cell types. Ninety-one percent of these DNA fragments showed significant transcriptional activity in at least one of the cell lines, whereas 89% showed activity in at least two of the lines. We analyzed the distributions of strengths of these promoter fragments in the different cell types and identified likely alternative promoters in a large fraction of the genes. These data indicate that this approach is an effective method for predicting human promoters and provide the first set of functional data collected in parallel for a large set of human promoters.
MeSH Terms
Cell Line
DNA, Complementary/genetics
DNA, Neoplasm/genetics
Databases, Genetic
Exons/genetics
Fibrosarcoma/chemistry,metabolism,pathology
HeLa Cells
Hepatocytes/chemistry,cytology,metabolism
Humans
Kidney/cytology
Promoter Regions, Genetic/genetics,physiology
Transcription, Genetic/genetics,physiology
Tumor Cells, Cultured
Chemicals
DNA, Complementary
DNA, Neoplasm
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Trinklein Nathan D
Department of Genetics, Stanford University School of Medicine, Stanford, California 94305-5120, USA.
Aldred Shelley J Force
Saldanha Alok J
Myers Richard M
References (13)
13 references, click to expand
-
The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation.
J Biol Chem. 1999 Dec 31;274(53):37511-6
PMID: 10608802
-
The genomic organization of human dystrobrevin.
Neurogenetics. 1997 May;1(1):37-42
PMID: 10735273
-
Identification and analysis of eukaryotic promoters: recent computational approaches.
Trends Genet. 2001 Feb;17(2):56-60
PMID: 11173099
-
Identification and characterization of the potential promoter regions of 1031 kinds of human genes.
Genome Res. 2001 May;11(5):677-84
PMID: 11337467
-
Construction of full-length-enriched cDNA libraries. The oligo-capping method.
Methods Mol Biol. 2001;175:143-53
PMID: 11462832
-
Computational identification of promoters and first exons in the human genome.
Nat Genet. 2001 Dec;29(4):412-7
PMID: 11726928
-
The mammalian gene collection.
Science. 1999 Oct 15;286(5439):455-7
PMID: 10521335
-
Computational detection and location of transcription start sites in mammalian genomic DNA.
Genome Res. 2002 Mar;12(3):458-61
PMID: 11875034
-
The human C4b-binding protein beta-chain gene.
J Biol Chem. 1993 Jul 15;268(20):15017-23
PMID: 8325877
-
Regulation of gene expression by alternative promoters.
FASEB J. 1996 Mar;10(4):453-60
PMID: 8647344
-
A map of 75 human ribosomal protein genes.
Genome Res. 1998 May;8(5):509-23
PMID: 9582194
-
Tissue-selective expression of alpha-dystrobrevin is determined by multiple promoters.
J Biol Chem. 1999 Mar 5;274(10):6250-8
PMID: 10037712
-
DBTSS: DataBase of human Transcriptional Start Sites and full-length cDNAs.
Nucleic Acids Res. 2002 Jan 1;30(1):328-31
PMID: 11752328